首页> 美国卫生研究院文献>other >Rigidification of a Flexible Protease Inhibitor Variant Upon Binding to Trypsin
【2h】

Rigidification of a Flexible Protease Inhibitor Variant Upon Binding to Trypsin

机译:刚性蛋白酶抑制剂变体绑定到胰蛋白酶的刚性化。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Tyr35→Gly replacement in bovine pancreatic trypsin inhibitor (BPTI) has previously been shown to dramatically enhance the flexibility of the trypsin-binding region of the free inhibitor and to destabilize the interaction with the protease by about 3 kcal/mol. The effects of this replacement on the enzyme-inhibitor interaction were further studied here by x-ray crystallography and isothermal titration calorimetry. The co-crystal structure of Y35G BPTI bound to trypsin was determined using 1.65 Å resolution x-ray diffraction data collected from cryopreserved crystals, and a new structure of the complex with wild-type BPTI under the same conditions was determined using 1.62 Å data. These structures reveal that, in contrast to the free protein, Y35G BPTI adopts a conformation nearly identical to that of the wild-type protein, with a water-filled cavity in place of the missing Tyr side chain. The crystallographic temperature factors for the two complexes indicate that the mutant inhibitor is nearly as rigid as the wild-type protein when bound to trypsin. Calorimetric measurements show that the change in enthalpy upon dissociation of the complex is 2.5 kcal/mol less favorable for the complex containing Y35G BPTI than for the complex with the wild-type inhibitor. Thus, the destabilization of the complex resulting from the Y35G replacement is due to a more favorable change in entropy upon dissociation. The heat capacity changes for dissociation of the mutant and wild-type complexes were very similar, suggesting that the entropic effects probably do not arise from solvation effects, but are more likely due to an increase in protein conformational entropy upon dissociation of the mutant inhibitor. These results define the biophysical role of a highly conserved core residue located outside of a protein-binding interface, demonstrating that Tyr35 has little impact on the trypsin-bound BPTI structure and acts primarily to define the structure of the free protein so as to maximize binding affinity.
机译:先前已显示,牛胰胰蛋白酶抑制剂(BPTI)中的Tyr35→Gly置换可显着增强游离抑制剂的胰蛋白酶结合区的柔韧性,并使与蛋白酶的相互作用不稳定约3 kcal / mol。本文通过X射线晶体学和等温滴定量热法进一步研究了这种替代对酶-抑制剂相互作用的影响。使用从低温保存的晶体收集的1.65分辨率X射线衍射数据确定与胰蛋白酶结合的Y35G BPTI的共晶体结构,并使用1.62数据确定在相同条件下具有野生型BPTI的复合物的新结构。这些结构表明,与游离蛋白相反,Y35G BPTI采用与野生型蛋白几乎相同的构象,并在充满水的空腔中替代了缺失的Tyr侧链。两种复合物的晶体温度因子表明,当与胰蛋白酶结合时,突变抑制剂几乎与野生型蛋白质一样坚硬。量热法测量显示,与含有野生型抑制剂的复合物相比,含Y35G BPTI的复合物对复合物解离后的焓变化的不利影响为2.5 kcal / mol。因此,由Y35G置换引起的复合物的去稳定化是由于解离时熵的更有利的变化引起的。突变体和野生型复合物解离的热容变化非常相似,表明熵效应可能不是由于溶剂化作用引起的,而是更有可能是由于突变体抑制剂解离后蛋白质构象熵的增加。这些结果定义了位于蛋白质结合界面之外的高度保守的核心残基的生物物理作用,表明Tyr35对胰蛋白酶结合的BPTI结构影响很小,并且主要用于定义游离蛋白质的结构,从而最大程度地提高结合力亲和力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号